Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Gilks

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
AIDS and Behavior|July 22, 2022
Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIVStephanie Edwards, Cheneal Puljević, Judith A Dean, et al.
The Journal of Infectious Diseases|May 10, 2002
Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in UgandaPontiano Kaleebu, Neil French, Cedric Mahe, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2017
Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan AfricaRuth L Goodall, David T Dunn, Peter Nkurunziza, et al.
BMC Family Practice|April 22, 2016
General Practitioner Antimicrobial Stewardship Programme Study (GAPS): protocol for a cluster randomised controlled trialMinyon L Avent, Malene Plejdrup Hansen, Charles Gilks, et al.
The Lancet. Infectious Diseases|June 27, 2009
Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysisRavindra K Gupta, Andrew Hill, Anthony W Sawyer, et al.
AIDS (London, England)|March 23, 2017
Hepatitis B serological markers and plasma DNA concentrationsHuw Price, David Dunn, Tamale Zachary, et al.
AIDS (London, England)|January 29, 2014
Exploring the population-level impact of antiretroviral treatment: the influence of baseline intervention contextSharmistha Mishra, Elisa Mountain, Michael Pickles, et al.
International Health|January 13, 2018
Patient-level benefits associated with decentralization of antiretroviral therapy services to primary health facilities in Malawi and UgandaGeorge Abongomera, Levison Chiwaula, Paul Revill, et al.
International Health|March 25, 2017
Impact of decentralisation of antiretroviral therapy services on HIV testing and care at a population level in Agago District in rural Northern Uganda: results from the Lablite population surveysGeorge Abongomera, Sylvia Kiwuwa-Muyingo, Paul Revill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 7, 2020
A Meta-analysis on the Role of Children in Severe Acute Respiratory Syndrome Coronavirus 2 in Household Transmission ClustersYanshan Zhu, Conor J Bloxham, Katina D Hulme, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
AIDS and Behavior|July 22, 2022
Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIVStephanie Edwards, Cheneal Puljević, Judith A Dean, et al.
The Journal of Infectious Diseases|May 10, 2002
Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in UgandaPontiano Kaleebu, Neil French, Cedric Mahe, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2017
Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan AfricaRuth L Goodall, David T Dunn, Peter Nkurunziza, et al.
BMC Family Practice|April 22, 2016
General Practitioner Antimicrobial Stewardship Programme Study (GAPS): protocol for a cluster randomised controlled trialMinyon L Avent, Malene Plejdrup Hansen, Charles Gilks, et al.
The Lancet. Infectious Diseases|June 27, 2009
Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysisRavindra K Gupta, Andrew Hill, Anthony W Sawyer, et al.
AIDS (London, England)|March 23, 2017
Hepatitis B serological markers and plasma DNA concentrationsHuw Price, David Dunn, Tamale Zachary, et al.
AIDS (London, England)|January 29, 2014
Exploring the population-level impact of antiretroviral treatment: the influence of baseline intervention contextSharmistha Mishra, Elisa Mountain, Michael Pickles, et al.
International Health|January 13, 2018
Patient-level benefits associated with decentralization of antiretroviral therapy services to primary health facilities in Malawi and UgandaGeorge Abongomera, Levison Chiwaula, Paul Revill, et al.
International Health|March 25, 2017
Impact of decentralisation of antiretroviral therapy services on HIV testing and care at a population level in Agago District in rural Northern Uganda: results from the Lablite population surveysGeorge Abongomera, Sylvia Kiwuwa-Muyingo, Paul Revill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 7, 2020
A Meta-analysis on the Role of Children in Severe Acute Respiratory Syndrome Coronavirus 2 in Household Transmission ClustersYanshan Zhu, Conor J Bloxham, Katina D Hulme, et al.
Pageof 4